A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors
Podophyllotoxin (PPT) exhibited significant activity against P-glycoprotein mediated
multidrug resistant (MDR) tumor cell lines; however, due to its poor solubility and high …
multidrug resistant (MDR) tumor cell lines; however, due to its poor solubility and high …
Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460
C Huisman, CG Ferreira, LE Bröker, JA Rodriguez… - Clinical cancer …, 2002 - AACR
Purpose: Here we report on the role of mitochondria, death receptors (DRs), and caspases
in exerting the cytotoxic effect of clinically relevant concentrations of paclitaxel in the non …
in exerting the cytotoxic effect of clinically relevant concentrations of paclitaxel in the non …
Anti-EGFR lipid micellar nanoparticles co-encapsulating quantum dots and paclitaxel for tumor-targeted theranosis
Cancer theranosis is an emerging field of personalized medicine which enables individual
anti-cancer treatment by monitoring the therapeutic responses of cancer patients. Based on …
anti-cancer treatment by monitoring the therapeutic responses of cancer patients. Based on …
A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine
Background and purpose: We report the development of a very efficient cell‐based high
throughput screening (HTS) method, which utilizes a novel bio‐sensor that selectively …
throughput screening (HTS) method, which utilizes a novel bio‐sensor that selectively …
Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies
Objective The aim of the study was to develop stable Paclitaxel nanocrystals (PTX/NCs) for
enhanced oral delivery of Paclitaxel (PTX) by circumventing its difficult solubilization …
enhanced oral delivery of Paclitaxel (PTX) by circumventing its difficult solubilization …
Fluoxetine enhances anti-tumor activity of paclitaxel in gastric adenocarcinoma cells by triggering apoptosis and necroptosis
TM Khing, WW Po, UD Sohn - Anticancer research, 2019 - ar.iiarjournals.org
Background/Aim: Fluoxetine, an antidepressant, has cytotoxic effects on several cancer cell
lines, while paclitaxel is an antineoplastic agent for various cancers. The aim of this study …
lines, while paclitaxel is an antineoplastic agent for various cancers. The aim of this study …
A 3D biomimetic model of tissue stiffness interface for cancer drug testing
CRI Lam, HK Wong, S Nai, CK Chua… - Molecular …, 2014 - ACS Publications
Contrary to oversimplified preclinical drug screens that derive treatment responses of cancer
cells grown on plastic cell culturing surfaces, the actual in vivo scenario for cancer cell …
cells grown on plastic cell culturing surfaces, the actual in vivo scenario for cancer cell …
In vitro combination characterization of the new anticancer plant drug β-elemene with taxanes against human lung carcinoma
J Zhao, QQ Li, B Zou, G Wang, X Li… - International …, 2007 - spandidos-publications.com
β-elemene has recently raised interest in PR China as a novel antitumor plant drug isolated
from the Chinese medicinal herb Zedoary. To explore potentially useful combinations of β …
from the Chinese medicinal herb Zedoary. To explore potentially useful combinations of β …
Efficient induction of apoptosis in cancer cells by paclitaxel-loaded selenium nanoparticles
Aim: To develop selenium nanoparticles (SeNPs)-based delivery systems for paclitaxel
(PTX) and assess their antiproliferative efficacy against cancer cells in vitro with potential …
(PTX) and assess their antiproliferative efficacy against cancer cells in vitro with potential …
Disulfide-bridged chitosan-eudragit S-100 nanoparticles for colorectal cancer
Covalently bonded Eudragit S-100 (EU) and chitosan (CS) based colon-specific
nanoparticles (CSE NPs) were fabricated as drug carriers for treating colorectal cancers …
nanoparticles (CSE NPs) were fabricated as drug carriers for treating colorectal cancers …